Aggressive surgical approach in patients with adrenal-only metastases from hepatocellular carcinoma enables higher survival rates than standard systemic therapyOACSCD
Aggressive surgical approach in patients with adrenal-only metastases from hepatocellular carcinoma enables higher survival rates than standard systemic therapy
Sorin T Alexandrescu;Adina E Croitoru;Razvan T Grigorie;Dana R Tomescu;Gabriela Droc;Mugur C Grasu;Irinel Popescu
Dan Setlacec Centre of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest 022328, RomaniaCarol Davila University of Medicine and Pharmacy, Bucharest 020021, RomaniaDepartment of Oncology, Fundeni Clinical Institute, Bucharest 022328, RomaniaFaculty of Medicine, Titu Maiorescu University, Bucharest 031593, RomaniaDan Setlacec Centre of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest 022328, RomaniaCarol Davila University of Medicine and Pharmacy, Bucharest 020021, RomaniaDan Tulbure Centre of Anesteziology and Intensive Care, Fundeni Clinical Institute, Bucharest 022328, Romania
Adrenal metastasesHepatocellular carcinomaAdrenal resectionSorafenib Survival
Adrenal metastasesHepatocellular carcinomaAdrenal resectionSorafenib Survival
《国际肝胆胰疾病杂志（英文版）》 2021 (1)
28-33,6
评论